Global /India /Healthcare /Drug Manufacturers - General /BLISSGVS
chevron_leftBack
Bliss GVS Pharma Ltd. logo

Bliss GVS Pharma Ltd.

BLISSGVS
NSE: BLISSGVS Delayed
276.76INR 3.5%
2.93 USD
As of 20 June 2026, Bliss GVS Pharma Ltd. has a market cap of $300.1M USD, ranking #18595 globally and #1032 in India. It ranks #1682 in the Healthcare sector, and #613 in the Drug Manufacturers - General industry.
Global Rank
18595
Country Rank
1032
Sector Rank
1682
Industry Rank
613
Key Stats
Market Cap
$300.1MUSD
28.32B INR
Enterprise Value
$288.11MUSD
27.2B INR
Revenue (TTM)
$91.97MUSD
8.68B INR
EBITDA (TTM)
$14.17MUSD
1.34B INR
Net Income (TTM)
$11.56MUSD
1.09B INR
EBITDA Margin
15%
Profit Margin
13%
PE Ratio
26.0
PS Ratio
3.3
PB Ratio
2.4
EV/EBITDA
19.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Shibroor Kamath open_in_new
Employees
966
Founded
1984
Website
blissgvs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.5% 3.3% 23% 59% 76% 120%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
BLISSGVS
Bliss GVS Pharma Ltd
ISIN: INE416D01022
Shares Out.:
105.789M1 Shares Float: 42.53M2
TV:
SA:
YF:
GF:
BA:
MS:
276.76 INR
Bombay Stock Exchange
MIC: XBOM
506197 (BLISSGVS)
Bliss GVS Pharma Ltd
ISIN: INE416D01022
TV:
SA:
YF:
GF:
BA:
MS:
267.75 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
15K%
39.1
DIVISLAB
$18.38B
1.73T INR
6K%
70.0
$15.17B
1.43T INR
5K%
63.0
$11.73B
1.11T INR
4K%
19.6
MANKIND
$9.87B
931.67B INR
3K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
3K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
254K%
38.1
JNJ
$547.28B
182K%
26.4
ABBV
$360.63B
120K%
97.4
$318.3B
256.25B CHF
106K%
19.9
AZN
$284.64B
215.59B GBP
95K%
27.6
MRK
$274.03B
91K%
15.1
chevron_leftBack